Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells

Julia Billiard(GlaxoSmithKline (United Kingdom)), Kevin J. Duffy(GlaxoSmithKline (United States))
Cancer & Metabolism
September 6, 2013
Cited by 236


Related Papers